Skip to main content
. 2016 Nov 7;7(49):81645–81660. doi: 10.18632/oncotarget.13162

Figure 1. Up-regulation of AREG mRNA is associated with reduced disease-free survival in patients with high-grade serous ovarian carcinoma.

Figure 1

The cBioPortal for Cancer Genomics was used to query high-grade serous ovarian carcinomas from The Cancer Genome Atlas (n=489) for up-regulation of AREG mRNA above the median. A. OncoPrint results of cases with elevated AREG mRNA across all 489 high-grade serous ovarian carcinomas. B and C. Overall (B) and disease-free (C) survival differences between samples without and with elevated AREG mRNA levels were displayed as Kaplan-Meier survival curves with the associated P value (Log-rank test).